Literature DB >> 11787214

[Meningeal carcinomatosis as the first manifestation of gastric adenocarcinoma].

F Janků1, J Dusková, L Petruzelka, L Krásná, I Nováková.   

Abstract

Gastric adenocarcinoma is rarely observed in patients under the age of 40. Meningeal carcinomatosis as a first manifestation of disease is absolutely unique. If meningeal involvement occurs it is usually secondary event in previously diagnosed tumor. The prognosis is very unfavorable associated with short term survival. In the treatment of this disease there night be used either chemotherapy administered via lumbar injection or radiotherapy or combination of both. This case study is one of very few cases reported in literature when meningeal carcinomatosis was a first sign of advanced gastric adenocarcinoma. 39 years old woman was admitted to our hospital with severe headache, diplopia and vomiting. Meningeal carcinomatosis with gastric primary was diagnosed. She was treated with combination of cytosine arabinosid (Cytosar), methotrexate (Methotrexat), hydrocortisone (Hydrocortisone) administered via intrathecal lumbar injection and whole brain radiation. As a main complication she experienced disseminated intravascular coagulopathy. The improvement of patient's condition following the initial treatment had a very limited duration and the patient died of bilateral pneumonia and cerebral edema 44th day after the admission.

Entities:  

Mesh:

Year:  2001        PMID: 11787214

Source DB:  PubMed          Journal:  Cas Lek Cesk        ISSN: 0008-7335


  2 in total

1.  Meningeal carcinomatosis: a metastasis from gastroesophageal junction adenocarcinoma.

Authors:  Tanya Dam; Aftab Mahmood; Kenneth Linville; Michael Bailey; Salim Surani
Journal:  Case Rep Med       Date:  2013-12-19

Review 2.  Intracranial hypertension as the primary symptom of gastric signet-ring cell carcinoma: A case report and literature review.

Authors:  Jiali Pu; Lingjia Xu; Xinzhen Yin; Baorong Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.